Variability in blood lipids affects the neutrophil to lymphocyte ratio in patients undergoing elective percutaneous coronary intervention: a retrospective study.

Zhao, Liding; Xu, Tian; Li, Ya; Luan, Yi; Lv, Qingbo; Fu, Guosheng; Zhang, Wenbin

Zhao, Liding; Xu, Tian; Li, Ya; Luan, Yi; Lv, Qingbo; Fu, Guosheng; Zhang, Wenbin.

Afiliación

Zhao L; Department of Cardiovascular Diseases, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, No 3 East of Qinchun Road, Hangzhou, Zhejiang, 310000, People's Republic of China.
Xu T; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China.
Li Y; Department of Cardiovascular Diseases, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, No 3 East of Qinchun Road, Hangzhou, Zhejiang, 310000, People's Republic of China.
Luan Y; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China.
Lv Q; Department of Cardiovascular Diseases, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, No 3 East of Qinchun Road, Hangzhou, Zhejiang, 310000, People's Republic of China.
Fu G; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, China.
Zhang W; Department of Cardiovascular Diseases, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, No 3 East of Qinchun Road, Hangzhou, Zhejiang, 310000, People's Republic of China.

Lipids Health Dis ; 19(1): 124, 2020 Jun 03.

Article en En | MEDLINE | ID: mdl-32493321

Asunto(s)

Aterosclerosis/sangre; Enfermedades Cardiovasculares/sangre; Inflamación/sangre; Lípidos/sangre; Anciano; Aterosclerosis/tratamiento farmacológico; Aterosclerosis/genética; Aterosclerosis/patología; Atorvastatina/uso terapéutico; Enfermedades Cardiovasculares/tratamiento farmacológico; Enfermedades Cardiovasculares/genética; Enfermedades Cardiovasculares/patología; HDL-Colesterol/genética; HDL-Colesterol/metabolismo; Femenino; Humanos; Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico; Inflamación/tratamiento farmacológico; Inflamación/genética; Inflamación/patología; Metabolismo de los Lípidos/efectos de los fármacos; Metabolismo de los Lípidos/genética; Linfocitos/metabolismo; Masculino; Persona de Mediana Edad; Neutrófilos/metabolismo; Neutrófilos/patología; Pronóstico; Factores de Riesgo

Palabras clave

Atherosclerosis; High-density lipoprotein cholesterol; Low-density lipoprotein cholesterol; Neutrophil to lymphocyte ratio; Percutaneous coronary intervention; Variability

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Aterosclerosis / Inflamación / Lípidos Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lipids Health Dis Asunto de la revista: BIOQUIMICA / METABOLISMO Año: 2020 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google